News
| 3 min read
Newly launched company hits the ground running with $70M in financing and a collaboration with Takeda
| 2 min read
Researchers have identified the protein that converts amino acids into the enzyme cofactor cysteine tryptophylquinone
| 3 min read
Libtayo receives full approval in locally advanced BCC and accelerated approval in metastatic BCC
| 3 min read
Fungi in the gut help in the fight against dangerous blood-borne fungal infections
| 3 min read
Parexel, NeoGenomics unite to improve and accelerate clinical trials with real-world genomics data
| 3 min read
FDA approves Tepmetko as a once-daily oral MET inhibitor for NSCLC with METex14 skipping alterations
| 3 min read
CARISMA receives full rights for use of CEVEC’s CAP technology in anti-tumor cell therapies
| 2 min read
Early research shows how mild defects in mitochondria can lead to behaviors similar to those seen in autism
| 4 min read
Novavax’s NVX-CoV2373 first to demonstrate clinical efficacy against the UK and South Africa variants of COVID-19
| 3 min read
Initial data from Regeneron's Phase 3 trial of REGEN-COV show that the passive vaccine reduces COVID-19 infections and viral shedding
| 3 min read
Mammoth Biosciences and Agilent team up to launch an automated solution for SARS-CoV-2 testing
